Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn’s Disease: Results From the Phase 3 GRAVITI Study
Articles > Article · 2025
Authors: Nalan Gülşen ÜNAL
GASTROENTEROLOGY, Journal Indexed in SCI Expanded, International, 2025, vol 169, pp 308-325